REDWOOD CITY, Calif.,
Jan. 10, 2020 /PRNewswire/
-- Nevro Corp. (NYSE: NVRO), a global medical device
company that is providing innovative, evidence-based solutions for
the treatment of chronic pain, today announced that it will host
and webcast an investor briefing at the North American
Neuromodulation Society (NANS 2020) in Las Vegas, NV on Saturday, January 25, 2020, beginning at
3:00 p.m. PST. Nevro Chairman,
CEO and President D. Keith Grossman
will host the event and will provide a business update and answer
questions from investors about the Company's latest
developments.
A live webcast of this event will be available on the Investors
section of Nevro's website at www.nevro.com. A webcast replay
will be available approximately one hour after the live webcast
ends and will be archived on the Company's website.
About Nevro
Headquartered in Redwood City, California, Nevro is a global
medical device company focused on providing innovative products
that improve the quality of life of patients suffering from
debilitating chronic pain. Nevro has developed and commercialized
the Senza spinal cord stimulation (SCS) system, an evidence-based,
non-pharmacologic neuromodulation platform for the treatment of
chronic pain. HF10 therapy has demonstrated the ability to reduce
or eliminate opioids in ≥65% of patients across six peer-reviewed
clinical studies. The Senza® System, Senza II™ System,
and the Senza® Omnia™ System are the only SCS
systems that deliver Nevro's proprietary HF10® therapy.
Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are
trademarks of Nevro Corp.
To learn more about Nevro, connect with us on LinkedIn, Twitter,
Facebook and Instagram.
Investor Relations:
Juliet
Cunningham
Vice President, Investor Relations
+1 650-433-3247
ir@nevro.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nevro-to-host-investor-briefing-at-north-american-neuromodulation-society-nans-2020-conference-300984769.html
SOURCE Nevro Corp.